Establishment Labs Submits Motiva Implants for FDA Approval in Breast Reconstruction
I'm PortAI, I can summarize articles.
Establishment Labs Holdings Inc. has submitted its Motiva® implants to the FDA for approval in primary and revision breast reconstruction. Previously approved for breast augmentation, this submission aims to expand the use of Motiva implants for women post-mastectomy. The Motiva Flora® tissue expander, already in use at over 200 cancer centers, features MRI-conditional integrated port technology. This news is for informational purposes only and should not be considered financial or legal advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments